Literature DB >> 33672002

Acceptability of Telegenetics for Families with Genetic Eye Diseases.

Suzannah Bell1, Urvi Karamchandani1, Kirsten Malcolmson1, Mariya Moosajee1,2,3,4.   

Abstract

Healthcare providers around the world have implemented remote routine consultations to minimise disruption during the COVID-19 pandemic. Virtual clinics are particularly suitable for patients with genetic eye diseases as they rely on detailed histories with genetic counselling. During April-June 2019, the opinion of carers of children with inherited eye disorders attending the ocular genetics service at Moorfields Eye Hospital NHS Foundation Trust (MEH) were canvassed. Sixty-five percent of families (n = 35/54) preferred to have investigations carried out locally rather than travel to MEH, with 64% opting for a virtual consultation to interpret the results. The most popular mode of remote contact was via telephone (14/31), with video call being least preferred (8/31). Hence, 54 families who had received a telephone consultation mid-pandemic (November 2020-January 2021) were contacted to re-evaluate the acceptability of telegenetics using the Clinical Genetics Satisfaction Indicator and Telemedicine Satisfaction Questionnaire. Overall, 50 carers participated (response rate 93%); 58% of participants found teleconsultations acceptable and 54% agreed they increased their access to care, but 67.5% preferred to be seen in person. Patient satisfaction was high with 90% strongly agreeing/agreeing they shared and received all necessary information. Ocular genetics is well-suited for remote service delivery, ideally alternated with face-to-face consultations.

Entities:  

Keywords:  genetic eye disease; ophthalmology; rare disease; remote consultations; service delivery; telegenetics; telemedicine

Year:  2021        PMID: 33672002     DOI: 10.3390/genes12020276

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  2 in total

1.  Provider and Patient Satisfaction with Telemedicine Voice Therapy During the COVID-19 Pandemic.

Authors:  Mary E Kim; Lauren Timmons Sund; Mariah Morton; James Kim; Janet S Choi; M Eugenia Castro
Journal:  J Voice       Date:  2022-07-18       Impact factor: 2.300

2.  Commentary: An eye on the genes.

Authors:  Arti Elhence; Samarth Agarwal
Journal:  Indian J Ophthalmol       Date:  2022-07       Impact factor: 2.969

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.